Latest Articles

Vivli, the Center for Clinical Research Data, recently issued a press release announcing the launch of the COVID-19 portal, designed to enable the sharing of completed interventional treatment trial data. Technology Networks spoke with Julie Wood, Vivli’s Director of Strategy and Operations, to learn more about the COVID-19 portal and discover how researchers can access the data within the portal.

In this article, Technology Networks explore the current global efforts underway to develop a vaccine against COVID-19.

In this article, we review two key questions that remain around the spread of the novel coronavirus SARS-CoV-2.

In this article, we delve into some of the cell signaling pathways involved in glaucoma and cancer and how they represent promising new approaches to treatment.

Each individual’s genetic makeup is slightly different from everyone else’s, so why are we all receiving the same medicine? To put it simply – the lucrative blockbuster business model, which has previously been the key to pharma success, is no longer viable. In a global and fast-moving world, in order to evolve, it’s time to examine new alternatives to the classic structure.

In this article, we explore the advancements of single-cell sequencing methods such as scATAC-seq, and how these methods allow the mapping of large cell populations, one cell at a time. How does this information enhance our understanding of the epigenome?

Drug development is the process of bringing a novel drug from “bench to bedside”. It can take 10 to 15 years for a drug to be designed, developed and approved for use in patients. Here, we take a closer look at the multi-step process of developing a drug – from start to finish.

We tend to take for granted the quality and safety of our most used medicines, but recently, potentially carcinogenic nitrosamine impurities were found in commercially available drugs. This discovery, and the measures taken to quickly mitigate any risks, highlight the role of advancing analytical technology in safeguarding consumer health.

ADME profoundly affects a drug’s properties and has long been a cornerstone of pharmacology and drug discovery. Recent years, however, have seen an evolution in ADME concepts. Here, we take a closer look at the impact personalized and computational approaches are having on a drug's pharmacology.

A recent study has demonstrated that stem cells located in endometrial glands are responsible for the endometrium’s ability to self-renew during growth and regeneration. Technology Networks spoke with Pradeep Tanwar, senior author of the study, and Shafiq Syed, first author, to learn more about the research and the significance of the findings.